Pub. Date : 2015 Aug
PMID : 25694334
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | This lysine conjugate is currently being considered for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer, and combines the anti-HER2 antibody trastuzumab (Herceptin( )), with the cytotoxic microtubule-inhibiting maytansine derivative, DM1. | Lysine | immunoglobulin heavy diversity 1-7 | Homo sapiens |